HIV molecular immunology database

 

Search the Epitope Variant and Escape Mutation Database

Help


Found 1 matching record:

Displaying record number 55322

HXB2 Location  gp160(311-320)   gp160 Epitope Map
View variants at this location
Epitope RGPGRAFVTI   Epitope Alignment
Variants
iGPGqAFyat   non-susceptible form
fGPGqAFyTn   non-susceptible form
iGPGRAFyTt   non-susceptible form
iGPGqtFyat   non-susceptible form
iGlGqAlyTt   non-susceptible form
lGPGqAFyat   non-susceptible form
iGPGRAFyat   non-susceptible form
iGPGqvFyrt   non-susceptible form
mGPGRvFyTt   non-susceptible form
Epitope Name H
Species (MHC/HLA mouse(H-2Dd)

Variant Details

Showing all: 9 variant(s).


Variant ID.  823
Epitope Seq.  RGPGRAFVTI
Variant Seq.  iGPGqAFyat
Mutations R/I I/T R/Q V/Y T/A
Epitope Location R1I I10T R5Q V8Y T9A
HXB2 Location R311I I320T R315Q V318Y T319A
Mutation Type NSF: non-susceptible form
Method CD8 T-cell Elispot - IFNy
Note There was no cross-reactivity seen with this epitope variant after immunization with Clade A containing index epitope


Variant ID.  824
Epitope Seq.  RGPGRAFVTI
Variant Seq.  fGPGqAFyTn
Mutations R/F I/N R/Q V/Y
Epitope Location R1F I10N R5Q V8Y
HXB2 Location R311F I320N R315Q V318Y
Mutation Type NSF: non-susceptible form
Method CD8 T-cell Elispot - IFNy
Note There was no cross-reactivity seen with this epitope variant after immunization with Clade A containing index epitope


Variant ID.  825
Epitope Seq.  RGPGRAFVTI
Variant Seq.  iGPGRAFyTt
Mutations R/I I/T V/Y
Epitope Location R1I I10T V8Y
HXB2 Location R311I I320T V318Y
Mutation Type NSF: non-susceptible form
Method CD8 T-cell Elispot - IFNy
Note There was no cross-reactivity seen with this epitope variant after immunization with Clade A containing index epitope


Variant ID.  826
Epitope Seq.  RGPGRAFVTI
Variant Seq.  iGPGqtFyat
Mutations R/I I/T R/Q A/T V/Y T/A
Epitope Location R1I I10T R5Q A6T V8Y T9A
HXB2 Location R311I I320T R315Q A316T V318Y T319A
Mutation Type NSF: non-susceptible form
Method CD8 T-cell Elispot - IFNy
Note There was no cross-reactivity seen with this epitope variant after immunization with Clade A containing index epitope


Variant ID.  827
Epitope Seq.  RGPGRAFVTI
Variant Seq.  iGlGqAlyTt
Mutations R/I I/T P/L R/Q F/L V/Y
Epitope Location R1I I10T P3L R5Q F7L V8Y
HXB2 Location R311I I320T P313L R315Q F317L V318Y
Mutation Type NSF: non-susceptible form
Method CD8 T-cell Elispot - IFNy
Note There was no cross-reactivity seen with this epitope variant after immunization with Clade A containing index epitope


Variant ID.  828
Epitope Seq.  RGPGRAFVTI
Variant Seq.  lGPGqAFyat
Mutations R/L I/T R/Q V/Y T/A
Epitope Location R1L I10T R5Q V8Y T9A
HXB2 Location R311L I320T R315Q V318Y T319A
Mutation Type NSF: non-susceptible form
Method CD8 T-cell Elispot - IFNy
Note There was no cross-reactivity seen with this epitope variant after immunization with Clade A containing index epitope


Variant ID.  829
Epitope Seq.  RGPGRAFVTI
Variant Seq.  iGPGRAFyat
Mutations R/I I/T V/Y T/A
Epitope Location R1I I10T V8Y T9A
HXB2 Location R311I I320T V318Y T319A
Mutation Type NSF: non-susceptible form
Method CD8 T-cell Elispot - IFNy
Note There was no cross-reactivity seen with this epitope variant after immunization with Clade A containing index epitope


Variant ID.  830
Epitope Seq.  RGPGRAFVTI
Variant Seq.  iGPGqvFyrt
Mutations R/I I/T R/Q A/V V/Y T/R
Epitope Location R1I I10T R5Q A6V V8Y T9R
HXB2 Location R311I I320T R315Q A316V V318Y T319R
Mutation Type NSF: non-susceptible form
Method CD8 T-cell Elispot - IFNy
Note There was no cross-reactivity seen with this epitope variant after immunization with Clade A containing index epitope


Variant ID.  831
Epitope Seq.  RGPGRAFVTI
Variant Seq.  mGPGRvFyTt
Mutations R/M I/T A/V V/Y
Epitope Location R1M I10T A6V V8Y
HXB2 Location R311M I320T A316V V318Y
Mutation Type NSF: non-susceptible form
Method CD8 T-cell Elispot - IFNy
Note There was no cross-reactivity seen with this epitope variant after immunization with Clade A containing index epitope

References

Larke2007 Natasha Larke, Eung-Jun Im, Ralf Wagner, Carolyn Williamson, Anna-Lise Williamson, Andrew J. McMichael, and Tomáš Hanke. Combined Single-Clade Candidate HIV-1 Vaccines Induce T Cell Responses Limited by Multiple Forms of In Vivo Immune Interference. Eur. J. Immunol., 37(2):566-577, Feb 2007. PubMed ID: 17230443. Show all entries for this paper.


Questions or comments? Contact us at immuno@lanl.gov
 
Operated by Los Alamos National Security, LLC, for the U.S. Department of Energy's National Nuclear Security Administration
Copyright © 2006-2017 LANS LLC All rights reserved | Disclaimer/Privacy

Dept of Health & Human Services Los Alamos National Institutes of Health